Skip to main content

Table 3 Changes in health-related quality of life (EQ5D scores) by EULAR response mean scores (95 % confidence intervals)

From: Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?

  None Moderate Good Difference moderate and good
CARDERA 0.02 (–0.03, 0.07) 0.18 (0.14, 0.23) 0.30 (0.24, 0.35) 0.12 (0.04, 0.19)
TACIT 0.00 (–0.13, 0.14) 0.15 (0.08, 0.21) 0.30 (0.22, 0.37) 0.15 (0.05, 0.25)
  1. EQ5D EuroQol-5D, EULAR European League Against Rheumatism, CARDERA cost-effectiveness of treatment strategies using combination of disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis, TACIT tumour necrosis factor inhibitors against combination intensive therapy